Nureca's subsidiary receives ISO 13485 certification for Indian medical device facility

The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries

India committed to promote green and climate resilient healthcare facilities: Dr Pawar

Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW

Biocon Foundation receives Mahatma Award 2022

The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities

Thermo Fisher Scientific emphasizes on the need for more disruptive technologies

Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.

Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial

Study achieves primary endpoint of radiographic progression-free survival

Glenmark launches Lobeglitazone in India for Uncontrolled Type 2 Diabetes in adults

Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).

Lupin receives approval from USFDA for Darunavir Tablets

The product will be manufactured at Lupin's facility in Nagpur, India.

Medcare acquires 60% stake in Skin III

This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.

AGC begins study to expand its Bio-CDMO capability in Japan

Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment

Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.